Department of Gynecology and Obstetrics, Endocrinology and Metabolism Research Center, School of Medicine, Arak University of Medical Sciences, Arak, Iran.
Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I.R., Iran.
J Ovarian Res. 2018 Sep 14;11(1):80. doi: 10.1186/s13048-018-0457-1.
The aim of this study was to evaluate the effect of the co-administration of probiotic and selenium on parameters of mental health, hormonal profiles, and biomarkers of inflammation and oxidative stress in women with PCOS. Data on the effects of selenium and probiotic co-supplementation on mental health, hormonal and inflammatory parameters of patients with polycystic ovary syndrome (PCOS) are scarce. This investigation was carried out to evaluate the effects of selenium and probiotic co-supplementation on mental health, hormonal and inflammatory parameters in women with PCOS.
This randomized, double-blinded, placebo-controlled clinical trial was conducted on 60 subjects, aged 18-40 years old. Participants were randomly allocated into two groups to intake 8 × 10 CFU/day probiotic plus 200 μg/day selenium supplements (n = 30) or placebo (n = 30) for 12 weeks. Hormonal and inflammatory parameters were measured at baseline and after the 12-week intervention.
Probiotic and selenium co-supplementation resulted in a significant improvement in beck depression inventory (β - 0.76; 95% CI, - 1.26, - 0.26; P = 0.003), general health questionnaire scores (β - 1.15; 95% CI, - 1.97, - 0.32; P = 0.007) and depression anxiety and stress scale scores (β - 1.49; 95% CI, - 2.59, - 0.39; P = 0.009) compared with the placebo. Furthermore, probiotic and selenium co-supplementation significantly reduced total testosterone (β - 0.26 ng/mL; 95% CI, - 0.51, - 0.02; P = 0.03), hirsutism (β - 0.43; 95% CI, - 0.74, - 0.11; P = 0.008), high-sensitivity C-reactive protein (hs-CRP) (β - 0.58 mg/L; 95% CI, - 0.97, - 0.19; P = 0.004) and malondialdehyde (MDA) levels (β - 0.29 μmol/L; 95% CI, - 0.56, - 0.02; P = 0.03), and significantly increased total antioxidant capacity (TAC) (β + 84.76 mmol/L; 95% CI, + 48.08, + 121.44; P < 0.001) and total glutathione (GSH) levels (β + 26.78 μmol/L; 95% CI, + 4.33, + 49.23; P = 0.02) compared with the placebo.
Overall, the co-administration of probiotic and selenium for 12 weeks to women with PCOS had beneficial effects on mental health parameters, serum total testosterone, hirsutism, hs-CRP, TAC, GSH and MDA levels. This study was prospectively registered in the Iranian website ( www.irct.ir ) for registration of clinical trials ( http://www.irct.ir : IRCT20170513033941N22).
IRCT20170513033941N22 .
本研究旨在评估益生菌和硒联合给药对多囊卵巢综合征(PCOS)女性心理健康、激素谱以及炎症和氧化应激生物标志物参数的影响。关于硒和益生菌联合补充对多囊卵巢综合征患者心理健康、激素和炎症参数影响的数据很少。本研究旨在评估硒和益生菌联合补充对多囊卵巢综合征女性心理健康、激素和炎症参数的影响。
这是一项随机、双盲、安慰剂对照的临床试验,共纳入 60 名年龄在 18-40 岁的受试者。参与者被随机分为两组,分别服用 8×10CFU/天的益生菌加 200μg/天的硒补充剂(n=30)或安慰剂(n=30),共 12 周。在基线和 12 周干预后测量激素和炎症参数。
与安慰剂相比,益生菌和硒联合补充可显著改善贝克抑郁量表(β-0.76;95%置信区间,-1.26,-0.26;P=0.003)、一般健康问卷评分(β-1.15;95%置信区间,-1.97,-0.32;P=0.007)和抑郁焦虑和压力量表评分(β-1.49;95%置信区间,-2.59,-0.39;P=0.009)。此外,益生菌和硒联合补充可显著降低总睾酮(β-0.26ng/mL;95%置信区间,-0.51,-0.02;P=0.03)、多毛症(β-0.43;95%置信区间,-0.74,-0.11;P=0.008)、高敏 C 反应蛋白(hs-CRP)(β-0.58mg/L;95%置信区间,-0.97,-0.19;P=0.004)和丙二醛(MDA)水平(β-0.29μmol/L;95%置信区间,-0.56,-0.02;P=0.03),并显著增加总抗氧化能力(TAC)(β+84.76mmol/L;95%置信区间,+48.08,+121.44;P<0.001)和总谷胱甘肽(GSH)水平(β+26.78μmol/L;95%置信区间,+4.33,+49.23;P=0.02)与安慰剂相比。
总之,益生菌和硒联合给药 12 周可改善多囊卵巢综合征女性的心理健康参数、血清总睾酮、多毛症、hs-CRP、TAC、GSH 和 MDA 水平。本研究在伊朗网站(www.irct.ir)进行了前瞻性注册,用于临床试验注册(http://www.irct.ir:IRCT20170513033941N22)。
IRCT20170513033941N22。